We’re Here To Solve Your Biggest Protein Challenges
We are a team of highly experienced scientists specialised in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system.
We are driven by a very focused passion for helping our partners solve their most critical and unique recombinant protein challenges.
Our stable and flexible ExpreS2 recombinant protein expression platform perfectly supports all phases of drug discovery, R&D and manufacturing.
Latest publications by Expres2ion Biotechnologies
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells